ID   CP24A_HUMAN             Reviewed;         514 AA.
AC   Q07973; Q15807; Q32ML3; Q5I2W7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   10-MAY-2017, entry version 158.
DE   RecName: Full=1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial;
DE            Short=24-OHase;
DE            Short=Vitamin D(3) 24-hydroxylase;
DE            EC=1.14.15.16 {ECO:0000269|PubMed:15574355};
DE   AltName: Full=Cytochrome P450 24A1;
DE   AltName: Full=Cytochrome P450-CC24;
DE   Flags: Precursor;
GN   Name=CYP24A1; Synonyms=CYP24;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8506296; DOI=10.1073/pnas.90.10.4543;
RA   Chen K.-S., Prahl J.M., Deluca H.F.;
RT   "Isolation and expression of human 1,25-dihydroxyvitamin D3 24-
RT   hydroxylase cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:4543-4547(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=15788398; DOI=10.1074/jbc.M414522200;
RA   Ren S., Nguyen L., Wu S., Encinas C., Adams J.S., Hewison M.;
RT   "Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism
RT   for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis.";
RL   J. Biol. Chem. 280:20604-20611(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-104.
RX   PubMed=7632726;
RA   Chen K.-S., DeLuca H.F.;
RT   "Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase
RT   gene promoter and identification of two vitamin D-responsive
RT   elements.";
RL   Biochim. Biophys. Acta 1263:1-9(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 258-514 (ISOFORM 1).
RX   PubMed=8266831; DOI=10.1002/jbmr.5650081114;
RA   Labuda M., Lemieux N., Tihy F., Prinster C., Glorieux F.H.;
RT   "Human 25-hydroxyvitamin D 24-hydroxylase cytochrome P450 subunit maps
RT   to a different chromosomal location than that of pseudovitamin D-
RT   deficient rickets.";
RL   J. Bone Miner. Res. 8:1397-1406(1993).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBSTRATE SPECIFICITY.
RX   PubMed=15574355; DOI=10.2741/1514;
RA   Sakaki T., Kagawa N., Yamamoto K., Inouye K.;
RT   "Metabolism of vitamin D3 by cytochromes P450.";
RL   Front. Biosci. 10:119-134(2005).
RN   [8]
RP   VARIANTS HCINF1 GLU-143 DEL; GLN-159; LYS-322; TRP-396 AND SER-409,
RP   AND CHARACTERIZATION OF VARIANTS HCINF1 GLU-143 DEL; GLN-159; LYS-322;
RP   TRP-396 AND SER-409.
RX   PubMed=21675912; DOI=10.1056/NEJMoa1103864;
RA   Schlingmann K.P., Kaufmann M., Weber S., Irwin A., Goos C., John U.,
RA   Misselwitz J., Klaus G., Kuwertz-Broking E., Fehrenbach H.,
RA   Wingen A.M., Guran T., Hoenderop J.G., Bindels R.J., Prosser D.E.,
RA   Jones G., Konrad M.;
RT   "Mutations in CYP24A1 and idiopathic infantile hypercalcemia.";
RL   N. Engl. J. Med. 365:410-421(2011).
CC   -!- FUNCTION: Has a role in maintaining calcium homeostasis. Catalyzes
CC       the NADPH-dependent 24-hydroxylation of calcidiol (25-
CC       hydroxyvitamin D(3)) and calcitriol (1-alpha,25-dihydroxyvitamin
CC       D(3)). The enzyme can perform up to 6 rounds of hydroxylation of
CC       calcitriol leading to calcitroic acid. It also shows 23-
CC       hydroxylating activity leading to 1-alpha,25-dihydroxyvitamin
CC       D(3)-26,23-lactone as end product. {ECO:0000269|PubMed:15574355}.
CC   -!- CATALYTIC ACTIVITY: Calcitriol + 2 reduced adrenodoxin + 2 H(+) +
CC       O(2) = calcitetrol + 2 oxidized adrenodoxin + H(2)O.
CC       {ECO:0000269|PubMed:15574355}.
CC   -!- CATALYTIC ACTIVITY: Calcidiol + 2 reduced adrenodoxin + 2 H(+) +
CC       O(2) = secalciferol + 2 oxidized adrenodoxin + H(2)O.
CC       {ECO:0000269|PubMed:15574355}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q07973-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q07973-2; Sequence=VSP_043101;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=CYP24-SV;
CC         IsoId=Q07973-3; Sequence=VSP_053367, VSP_053368;
CC         Note=Specifically expressed in macrophages. Lacks the transit
CC         peptide. May be a dominant negative-acting isoform possibly by
CC         sequestering vitamin D metabolites.;
CC   -!- DISEASE: Hypercalcemia, infantile, 1 (HCINF1) [MIM:143880]: A
CC       disorder characterized by abnormally high level of calcium in the
CC       blood, failure to thrive, vomiting, dehydration, and
CC       nephrocalcinosis. {ECO:0000269|PubMed:21675912}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13286; AAA62379.1; -; mRNA.
DR   EMBL; AY858838; AAW50795.1; -; mRNA.
DR   EMBL; AL138805; CAB91829.1; -; Genomic_DNA.
DR   EMBL; AL138805; CAM27343.1; -; Genomic_DNA.
DR   EMBL; BC109083; AAI09084.1; -; mRNA.
DR   EMBL; BC109084; AAI09085.1; -; mRNA.
DR   EMBL; U60669; AAB03776.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; S67623; AAB29308.1; -; mRNA.
DR   CCDS; CCDS33491.1; -. [Q07973-1]
DR   CCDS; CCDS46616.1; -. [Q07973-2]
DR   PIR; A47436; A47436.
DR   PIR; I55488; I55488.
DR   RefSeq; NP_000773.2; NM_000782.4. [Q07973-1]
DR   RefSeq; NP_001122387.1; NM_001128915.1. [Q07973-2]
DR   RefSeq; XP_005260361.1; XM_005260304.4. [Q07973-1]
DR   RefSeq; XP_016883180.1; XM_017027691.1. [Q07973-1]
DR   RefSeq; XP_016883181.1; XM_017027692.1. [Q07973-1]
DR   RefSeq; XP_016883182.1; XM_017027693.1. [Q07973-2]
DR   UniGene; Hs.89663; -.
DR   ProteinModelPortal; Q07973; -.
DR   SMR; Q07973; -.
DR   BioGrid; 107963; 4.
DR   IntAct; Q07973; 2.
DR   MINT; MINT-6773699; -.
DR   STRING; 9606.ENSP00000216862; -.
DR   BindingDB; Q07973; -.
DR   ChEMBL; CHEMBL4521; -.
DR   DrugBank; DB00146; Calcidiol.
DR   DrugBank; DB02300; Calcipotriol.
DR   DrugBank; DB00136; Calcitriol.
DR   DrugBank; DB01285; Corticotropin.
DR   DrugBank; DB05024; CTA018.
DR   DrugBank; DB00153; Ergocalciferol.
DR   DrugBank; DB00910; Paricalcitol.
DR   GuidetoPHARMACOLOGY; 1365; -.
DR   SwissLipids; SLP:000001269; -.
DR   iPTMnet; Q07973; -.
DR   PhosphoSitePlus; Q07973; -.
DR   BioMuta; CYP24A1; -.
DR   DMDM; 19862747; -.
DR   MaxQB; Q07973; -.
DR   PaxDb; Q07973; -.
DR   PeptideAtlas; Q07973; -.
DR   PRIDE; Q07973; -.
DR   Ensembl; ENST00000216862; ENSP00000216862; ENSG00000019186. [Q07973-1]
DR   Ensembl; ENST00000395954; ENSP00000379284; ENSG00000019186. [Q07973-3]
DR   Ensembl; ENST00000395955; ENSP00000379285; ENSG00000019186. [Q07973-2]
DR   GeneID; 1591; -.
DR   KEGG; hsa:1591; -.
DR   UCSC; uc002xwu.2; human. [Q07973-1]
DR   CTD; 1591; -.
DR   DisGeNET; 1591; -.
DR   GeneCards; CYP24A1; -.
DR   HGNC; HGNC:2602; CYP24A1.
DR   HPA; HPA022261; -.
DR   HPA; HPA063771; -.
DR   MalaCards; CYP24A1; -.
DR   MIM; 126065; gene.
DR   MIM; 143880; phenotype.
DR   neXtProt; NX_Q07973; -.
DR   OpenTargets; ENSG00000019186; -.
DR   Orphanet; 300547; Autosomal recessive infantile hypercalcemia.
DR   PharmGKB; PA27097; -.
DR   eggNOG; KOG0159; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000119243; -.
DR   HOGENOM; HOG000276540; -.
DR   HOVERGEN; HBG099053; -.
DR   InParanoid; Q07973; -.
DR   KO; K07436; -.
DR   OMA; DYREEGY; -.
DR   OrthoDB; EOG091G0MI3; -.
DR   PhylomeDB; Q07973; -.
DR   TreeFam; TF105094; -.
DR   BioCyc; MetaCyc:HS00395-MONOMER; -.
DR   BRENDA; 1.14.13.159; 2681.
DR   Reactome; R-HSA-196791; Vitamin D (calciferol) metabolism.
DR   Reactome; R-HSA-211916; Vitamins.
DR   SABIO-RK; Q07973; -.
DR   ChiTaRS; CYP24A1; human.
DR   GeneWiki; CYP24A1; -.
DR   GenomeRNAi; 1591; -.
DR   PRO; PR:Q07973; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000019186; -.
DR   CleanEx; HS_CYP24A1; -.
DR   Genevisible; Q07973; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0030342; F:1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity; IDA:UniProtKB.
DR   GO; GO:0008403; F:25-hydroxycholecalciferol-24-hydroxylase activity; IEA:Ensembl.
DR   GO; GO:0020037; F:heme binding; TAS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; NAS:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; IEP:BHF-UCL.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0033280; P:response to vitamin D; IDA:BHF-UCL.
DR   GO; GO:0042369; P:vitamin D catabolic process; NAS:BHF-UCL.
DR   GO; GO:0042359; P:vitamin D metabolic process; TAS:Reactome.
DR   GO; GO:0070561; P:vitamin D receptor signaling pathway; NAS:BHF-UCL.
DR   GO; GO:0006766; P:vitamin metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation; Heme; Iron;
KW   Metal-binding; Mitochondrion; Monooxygenase; NADP; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     35       Mitochondrion. {ECO:0000250}.
FT   CHAIN        36    514       1,25-dihydroxyvitamin D(3) 24-
FT                                hydroxylase, mitochondrial.
FT                                /FTId=PRO_0000003615.
FT   METAL       462    462       Iron (heme axial ligand). {ECO:0000250}.
FT   VAR_SEQ       1      8       MSSPISKS -> MYSCFSHR (in isoform 3).
FT                                {ECO:0000303|PubMed:15788398}.
FT                                /FTId=VSP_053367.
FT   VAR_SEQ       9    150       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15788398}.
FT                                /FTId=VSP_053368.
FT   VAR_SEQ     413    478       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043101.
FT   VARIANT     143    143       Missing (in HCINF1; complete loss of
FT                                function). {ECO:0000269|PubMed:21675912}.
FT                                /FTId=VAR_066408.
FT   VARIANT     157    157       R -> Q (in dbSNP:rs35051736).
FT                                /FTId=VAR_048464.
FT   VARIANT     159    159       R -> Q (in HCINF1; complete loss of
FT                                function; dbSNP:rs387907322).
FT                                {ECO:0000269|PubMed:21675912}.
FT                                /FTId=VAR_066409.
FT   VARIANT     322    322       E -> K (in HCINF1; complete loss of
FT                                function; dbSNP:rs387907324).
FT                                {ECO:0000269|PubMed:21675912}.
FT                                /FTId=VAR_066410.
FT   VARIANT     374    374       M -> T (in dbSNP:rs6022990).
FT                                /FTId=VAR_048465.
FT   VARIANT     396    396       R -> W (in HCINF1; complete loss of
FT                                function; dbSNP:rs114368325).
FT                                {ECO:0000269|PubMed:21675912}.
FT                                /FTId=VAR_066411.
FT   VARIANT     409    409       L -> S (in HCINF1; retains small but
FT                                measurable levels of activity;
FT                                dbSNP:rs6068812).
FT                                {ECO:0000269|PubMed:21675912}.
FT                                /FTId=VAR_048466.
FT   CONFLICT     68     68       G -> A (in Ref. 1; AAA62379/AAB03776).
FT                                {ECO:0000305}.
FT   CONFLICT    124    125       AY -> V (in Ref. 1; AAA62379).
FT                                {ECO:0000305}.
FT   CONFLICT    270    270       D -> G (in Ref. 1; AAA62379).
FT                                {ECO:0000305}.
FT   CONFLICT    365    365       V -> R (in Ref. 1; AAA62379).
FT                                {ECO:0000305}.
FT   CONFLICT    368    368       A -> E (in Ref. 1; AAA62379).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       S -> G (in Ref. 1; AAA62379).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       F -> S (in Ref. 6; AAB29308).
FT                                {ECO:0000305}.
SQ   SEQUENCE   514 AA;  58875 MW;  8862F63771981195 CRC64;
     MSSPISKSRS LAAFLQQLRS PRQPPRLVTS TAYTSPQPRE VPVCPLTAGG ETQNAAALPG
     PTSWPLLGSL LQILWKGGLK KQHDTLVEYH KKYGKIFRMK LGSFESVHLG SPCLLEALYR
     TESAYPQRLE IKPWKAYRDY RKEGYGLLIL EGEDWQRVRS AFQKKLMKPG EVMKLDNKIN
     EVLADFMGRI DELCDERGHV EDLYSELNKW SFESICLVLY EKRFGLLQKN AGDEAVNFIM
     AIKTMMSTFG RMMVTPVELH KSLNTKVWQD HTLAWDTIFK SVKACIDNRL EKYSQQPSAD
     FLCDIYHQNR LSKKELYAAV TELQLAAVET TANSLMWILY NLSRNPQVQQ KLLKEIQSVL
     PENQVPRAED LRNMPYLKAC LKESMRLTPS VPFTTRTLDK ATVLGEYALP KGTVLMLNTQ
     VLGSSEDNFE DSSQFRPERW LQEKEKINPF AHLPFGVGKR MCIGRRLAEL QLHLALCWIV
     RKYDIQATDN EPVEMLHSGT LVPSRELPIA FCQR
//
